HBV News and Research

RSS

Study reveals promising results for primary liver cancer patients treated with SIR-Spheres Y-90 resin microspheres

Patients with advanced or inoperable Hepatocellular Carcinoma (HCC) who usually received one or two treatments with liver-directed SIR-Spheres Y-90 resin microspheres in the 459-patient French SARAH study had similar survival compared to patients who received standard twice-daily systemic treatment with sorafenib, but with less than half the number and significantly fewer severe treatment-related adverse effects and significantly better Quality of Life, according to data presented here at The International Liver Congress™ 2017.

26 Apr 2017

Statins may provide favorable outcomes to patients with HBV- or HCV-related cirrhosis

Infection with hepatitis B virus (HBV) or hepatitis C virus (HCV) can lead to cirrhosis as well as liver cancer. A Hepatology study from Taiwan has found that statins may provide benefits to patients with HBV- or HCV-related cirrhosis.

24 Apr 2017

WHO Global Hepatitis Report reveals goal to eliminate viral hepatitis by 2030

The World Health Organization (WHO) has published the first-ever Global Hepatitis Report. The World Hepatitis Alliance (WHA) welcomes the publication, which is a follow-up to WHO’s Global Strategy on Viral Hepatitis, and has set the goal to eliminate viral hepatitis as a public health threat by 2030.

21 Apr 2017

FDA grants approval for two drugs to treat hepatitis C virus in children

The U.S. Food and Drug Administration today approved supplemental applications for Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir) to treat hepatitis C virus (HCV) in children ages 12 to 17. Harvoni and Sovaldi were previously approved to treat HCV in adults.

7 Apr 2017

ECDC guidance aims to improve antenatal screening for infections to avoid mother-to-child transmission

Transmission of infections with HIV, hepatitis B, syphilis or rubella from mother to child before and during birth as well as in infancy still occur across Europe - despite existing prevention methods.

21 Mar 2017

Quest Diagnostics introduces new HBV test service to help evaluate patient’s response to drug therapies

24 Jan 2017

A test to evaluate Hepatitis B therapy launched by Quest Diagnostics

Quest Diagnostics, the world’s leading provider of diagnostic information services, today announced the launch of a new test service that helps physicians evaluate a patient’s response to drug therapies used to treat infection with the hepatitis B virus (HBV). The first test of its kind available in the United States, the test is significant because it may help physicians tailor more effective treatments for the up to 2.2 million individuals infected with HBV.

23 Jan 2017

Georgia State University, GeoVax join forces to advance development of Hepatitis B therapeutic vaccine

The Georgia State University Research Foundation has entered into a research collaboration agreement with GeoVax Labs, Inc., a Georgia-based biotechnology company developing human vaccines, to advance development of a therapeutic vaccine for treatment of chronic Hepatitis B infections.

18 Jan 2017

Research provides insight into molecular mechanisms involved in immune response to HBV

The innate immune system in mammals defends against infection from viruses and other microbial infections.

28 Nov 2016

FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

Amgen today announced that the U.S. Food and Drug Administration has approved the supplemental Biologics License Application for the expanded use of ENBREL (etanercept), making it the first and only systemic therapy to treat pediatric patients (ages 4-17) with chronic moderate-to-severe plaque psoriasis.

7 Nov 2016

Community outreach workers may help increase HBV vaccination rates to cut risk of liver cancer

Liver cancer is more common among Asian Americans in part because they are at high risk of HBV infection.

12 Oct 2016

MU researcher awarded $3 million NIH grant to develop new drugs for treating HBV

Hepatitis B (HBV) is a viral infection that increases the likelihood of developing liver cancer or liver failure.

26 Sep 2016

New vaccine against grass pollen allergies may help combat hepatitis B infection

A new type of vaccine against grass pollen allergies (BM32) might also offer an effective treatment for combating hepatitis B infection.

8 Sep 2016

New report urges all European countries to adopt universal vaccination for hepatitis

To coincide with World Hepatitis Day, a new report, commissioned by United European Gastroenterology, calls for all European countries to adopt universal vaccination and harmonised screening programmes for hepatitis, as well as improved neonatal screening, to help speed up the eradication of the disease.

1 Aug 2016

HBV News and Research

Study reveals promising results for primary liver cancer patients treated with SIR-Spheres Y-90 resin microspheres

Statins may provide favorable outcomes to patients with HBV- or HCV-related cirrhosis

WHO Global Hepatitis Report reveals goal to eliminate viral hepatitis by 2030

FDA grants approval for two drugs to treat hepatitis C virus in children

ECDC guidance aims to improve antenatal screening for infections to avoid mother-to-child transmission

Quest Diagnostics introduces new HBV test service to help evaluate patient’s response to drug therapies

A test to evaluate Hepatitis B therapy launched by Quest Diagnostics

Georgia State University, GeoVax join forces to advance development of Hepatitis B therapeutic vaccine

Research provides insight into molecular mechanisms involved in immune response to HBV

FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

Community outreach workers may help increase HBV vaccination rates to cut risk of liver cancer

MU researcher awarded $3 million NIH grant to develop new drugs for treating HBV

New vaccine against grass pollen allergies may help combat hepatitis B infection

New report urges all European countries to adopt universal vaccination for hepatitis

New screen-and-treat programme for hepatitis B may thwart deadly complications of disease

AAPS Foundation announces winner of 2016 New Investigator Grant

FIB-4 index predicts HBV-related HCC

Infant HBV vaccination prevents HCC in children, young adults

TDF reduces vertical HBV transmission

'Simple' model predicts PegIFN response in chronic HBV

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News